CAL-54
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-365, RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
DSMZ |
ACC-365 |
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
Calu-6
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0236
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1855224 PMID:2388294 PMID:3129183 PMID:3335022 PMID:3518877 PMID:3940644 PMID:6148444 PMID:6935474 PMID:7459858 PMID:7834619 PMID:7972006 PMID:8385084 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:20679594 PMID:22460905 PMID:22961666 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28273808 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
CaLu-6, CALU-6, Calu.6, Calu 6, Calu6, CALU6, CaLu-06 |
|
|
BTO:BTO_0002235, CLO:CLO_0002193, EFO:EFO_0002152, MCCL:MCC:0000125, CLDB:cl636, CLDB:cl638, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-56, BioGRID_ORCS_Cell_line:587, BioSample:SAMN03473148, BioSample:SAMN10987791, cancercelllines:CVCL_0236, CancerTools:161924, CCRID:1101HUM-PUMC000813, CCRID:3101HUMTCHu144, Cell_Model_Passport:SIDM00921, ChEMBL-Cells:CHEMBL3307639, ChEMBL-Targets:CHEMBL614535, CLS:300135, Cosmic:724859, Cosmic:929969, Cosmic:933575, Cosmic:934466, Cosmic:934542, Cosmic:1071885, Cosmic:1089230, Cosmic:1146874, Cosmic:1176611, Cosmic:1434959, Cosmic:1995360, Cosmic:2668262, Cosmic-CLP:724859, DepMap:ACH-000264, DSMZ:ACC-734, DSMZCellDive:ACC-734, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724859, GEO:GSM108805, GEO:GSM108806, GEO:GSM253341, GEO:GSM434325, GEO:GSM513938, GEO:GSM514319, GEO:GSM794263, GEO:GSM817065, GEO:GSM843487, GEO:GSM886916, GEO:GSM887982, GEO:GSM1374435, GEO:GSM1374436, GEO:GSM1669659, IARC_TP53:119, IARC_TP53:21265, ICLC:HTL97003, IGRhCellID:Calu6, KCLB:30056, LiGeA:CCLE_215, LINCS_LDP:LCL-1626, Lonza:1139, NCBI_Iran:C431, PharmacoDB:Calu6_180_2019, PRIDE:PXD025499, PRIDE:PXD030304, Progenetix:CVCL_0236, PubChem_Cell_line:CVCL_0236, Wikidata:Q54808427 |
|
|
CVCL_0236 |
2026-08-15 04:19:57 |
35 |
CAL-62
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1112
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1369551 PMID:18713817 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23833040 PMID:25365311 PMID:27397505 PMID:30737244 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
Cal-62, CAL 62, Cal 62, CAL62, Centre Antoine Lacassagne-62 |
|
|
BTO:BTO_0002146, CLO:CLO_0002187, EFO:EFO_0002126, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473548, BioSample:SAMN10988563, cancercelllines:CVCL_1112, CCRID:3101HUMSCSP546, Cell_Model_Passport:SIDM00931, ChEMBL-Cells:CHEMBL3308099, ChEMBL-Targets:CHEMBL1075413, CLS:305114, Cosmic:891257, Cosmic:906828, Cosmic:1152118, Cosmic:1162838, Cosmic:1239974, Cosmic:2054116, Cosmic:2613252, Cosmic-CLP:906828, DepMap:ACH-000174, DSMZ:ACC-448, DSMZCellDive:ACC-448, EGA:EGAS00001000978, GDSC:906828, GEO:GSM886911, GEO:GSM887977, GEO:GSM1669654, IARC_TP53:21213, IGRhCellID:CAL62, LiGeA:CCLE_550, LINCS_LDP:LCL-1683, PharmacoDB:CAL62_174_2019, PRIDE:PXD030304, Progenetix:CVCL_1112, PubChem_Cell_line:CVCL_1112, Wikidata:Q54808410 |
|
|
CVCL_1112 |
2026-08-15 04:19:59 |
14 |
CAL-29
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1808
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2440566 PMID:11720483 PMID:20215515 PMID:22460905 PMID:24035680 PMID:24367658 PMID:26589293 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
CAL 29, CAL29, Centre Antoine Lacassagne-29 |
|
|
CLO:CLO_0037157, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:584, BioSample:SAMN03473515, BioSample:SAMN10988514, cancercelllines:CVCL_1808, Cell_Model_Passport:SIDM00936, Cosmic:1285115, Cosmic:1995357, Cosmic:2050440, Cosmic:2057444, Cosmic:2444248, Cosmic:2685941, Cosmic-CLP:1290730, DepMap:ACH-000142, DSMZ:ACC-515, DSMZCellDive:ACC-515, EGA:EGAS00001000978, GDSC:1290730, GEO:GSM827161, GEO:GSM886908, GEO:GSM887973, GEO:GSM1669649, IARC_TP53:28275, LiGeA:CCLE_765, LINCS_LDP:LCL-1711, PharmacoDB:CAL29_169_2019, PRIDE:PXD030304, Progenetix:CVCL_1808, Wikidata:Q54808396 |
|
|
CVCL_1808 |
2026-08-15 04:19:56 |
4 |
CAL-27
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1107
|
Homo sapiens (Human)
|
Tongue adenosquamous carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2145926 PMID:2440566 PMID:3181269 PMID:19631575 PMID:20014447 PMID:20164919 PMID:21868764 PMID:22460905 PMID:24201445 PMID:25275298 PMID:25485619 PMID:25877200 PMID:25888065 PMID:26589293 PMID:27108184 PMID:27397505 PMID:28196595 PMID:28476783 PMID:29156801 PMID:29770536 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34977030 PMID:35839778 PMID:36912284
|
Cancer cell line
|
Male |
Cal-27, CAL 27, Cal 27, CAL27, Cal27, CAL-SCC-27, Centre Antoine Lacassagne-27 |
|
|
BTO:BTO_0000921, CLO:CLO_0002178, CLO:CLO_0002182, EFO:EFO_0006366, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2095, BCRJ:0326, BioGRID_ORCS_Cell_line:336, BioSample:SAMN03471886, BioSample:SAMN10987905, cancercelllines:CVCL_1107, CCRID:1101HUM-PUMC000338, CCRID:4201HUM-CCTCC00248, CCTCC:GDC0248, Cell_Model_Passport:SIDM00937, ChEMBL-Cells:CHEMBL3308098, ChEMBL-Targets:CHEMBL1075408, CLS:305029, Cosmic:686972, Cosmic:910916, Cosmic:1006469, Cosmic:1017793, Cosmic:1041674, Cosmic:1339913, Cosmic:1466800, Cosmic:1530734, Cosmic:1752762, Cosmic:2043896, Cosmic:2131842, Cosmic:2296292, Cosmic-CLP:910916, DepMap:ACH-000832, DSMZ:ACC-446, DSMZCellDive:ACC-446, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910916, GEO:GSM422868, GEO:GSM423671, GEO:GSM886907, GEO:GSM887972, GEO:GSM1374427, GEO:GSM1374428, GEO:GSM1519074, GEO:GSM1519075, GEO:GSM1519076, GEO:GSM1669648, IARC_TP53:17482, IGRhCellID:CAL27%20GSE9585, LiGeA:CCLE_698, LINCS_LDP:LCL-1215, PharmacoDB:CAL27_168_2019, PRIDE:PXD002132, PRIDE:PXD028810, PRIDE:PXD029420, PRIDE:PXD030304, Progenetix:CVCL_1107, PubChem_Cell_line:CVCL_1107, Wikidata:Q54808394 |
|
|
CVCL_1107 |
2026-08-15 04:19:59 |
368 |
CAL-54
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1111
|
Homo sapiens (Human)
|
Renal cell carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8868943 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28489074 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Male |
CAL 54, CAL54, Centre Antoine Lacassagne-54 |
|
|
CLO:CLO_0002186, EFO:EFO_0002125, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473166, BioSample:SAMN10988487, cancercelllines:CVCL_1111, Cell_Model_Passport:SIDM00932, ChEMBL-Cells:CHEMBL3308346, ChEMBL-Targets:CHEMBL1075412, Cosmic:910952, Cosmic-CLP:910952, DepMap:ACH-000457, DSMZ:ACC-365, DSMZCellDive:ACC-365, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910952, GEO:GSM886910, GEO:GSM887976, GEO:GSM1669653, IARC_TP53:21212, IGRhCellID:CAL54, LiGeA:CCLE_129, LINCS_LDP:LCL-1757, PharmacoDB:CAL54_173_2019, PRIDE:PXD030304, Progenetix:CVCL_1111, PubChem_Cell_line:CVCL_1111, Wikidata:Q54808409 |
|
|
CVCL_1111 |
2026-08-15 04:19:56 |
1 |
CAMA-1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1115
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:833871 PMID:924690 PMID:3518877 PMID:6582512 PMID:6935474 PMID:7017212 PMID:7459858 PMID:10862037 PMID:11343771 PMID:12353263 PMID:12661003 PMID:12800145 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19593635 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22585861 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
Cama-1, CAMA1, CAMA |
|
|
BTO:BTO_0005022, CLO:CLO_0002194, EFO:EFO_0001100, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-21, BioGRID_ORCS_Cell_line:588, BioSample:SAMN03472698, BioSample:SAMN10987851, cancercelllines:CVCL_1115, CancerTools:161925, Cell_Model_Passport:SIDM00920, ChEMBL-Cells:CHEMBL3308719, ChEMBL-Targets:CHEMBL1075416, Cosmic:687468, Cosmic:871153, Cosmic:904354, Cosmic:946382, Cosmic:997930, Cosmic:1000130, Cosmic:1046925, Cosmic:1047717, Cosmic:1136349, Cosmic:1287905, Cosmic:1289386, Cosmic:1603195, Cosmic:1995361, Cosmic:2165018, Cosmic:2750520, Cosmic-CLP:946382, DepMap:ACH-000783, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:946382, GEO:GSM344344, GEO:GSM344394, GEO:GSM378143, GEO:GSM421864, GEO:GSM783930, GEO:GSM827295, GEO:GSM843488, GEO:GSM843489, GEO:GSM847248, GEO:GSM847458, GEO:GSM886917, GEO:GSM887983, GEO:GSM984230, GEO:GSM1008894, GEO:GSM1053694, GEO:GSM1172856, GEO:GSM1172948, GEO:GSM1215264, GEO:GSM1238119, GEO:GSM1374437, GEO:GSM1661977, GEO:GSM1669660, IARC_TP53:18372, LiGeA:CCLE_527, LINCS_HMS:50131, LINCS_LDP:LCL-1466, Lonza:1251, PharmacoDB:CAMA1_181_2019, PRIDE:PXD002486, PRIDE:PXD030304, Progenetix:CVCL_1115, PubChem_Cell_line:CVCL_1115, SLKBase:3405, Wikidata:Q54808432 |
|
|
CVCL_1115 |
2026-08-15 04:19:57 |
31 |
CAL-51
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1110
|
Homo sapiens (Human)
|
Breast carcinoma
|
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:2390488 PMID:10969801 PMID:11044355 PMID:12661003 PMID:12800145 PMID:15677628 PMID:19582160 PMID:20164919 PMID:20215515 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23122841 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34339474 PMID:35839778 PMID:36476833
|
Cancer cell line
|
Female |
CAL 51, CAL51, Cal51, Centre Antoine Lacassagne-51 |
|
|
BTO:BTO_0000945, CLO:CLO_0002185, EFO:EFO_0005358, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:585, BioSample:SAMN03473159, BioSample:SAMN10988576, cancercelllines:CVCL_1110, Cell_Model_Passport:SIDM00933, ChEMBL-Cells:CHEMBL3308717, ChEMBL-Targets:CHEMBL1075411, Cosmic:687467, Cosmic:910927, Cosmic:1057761, Cosmic:2164986, Cosmic-CLP:910927, DepMap:ACH-000856, DSMZ:ACC-302, DSMZCellDive:ACC-302, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910927, GEO:GSM115099, GEO:GSM217567, GEO:GSM274645, GEO:GSM274646, GEO:GSM344362, GEO:GSM344412, GEO:GSM350521, GEO:GSM459702, GEO:GSM783973, GEO:GSM827162, GEO:GSM847246, GEO:GSM847456, GEO:GSM886909, GEO:GSM887975, GEO:GSM1172946, GEO:GSM1374429, GEO:GSM1664565, GEO:GSM1669652, IARC_TP53:21211, IGRhCellID:CAL51, LiGeA:CCLE_143, LINCS_HMS:50008, LINCS_LDP:LCL-1472, Lonza:1002, PharmacoDB:CAL51_172_2019, PRIDE:PXD000953, PRIDE:PXD030304, Progenetix:CVCL_1110, PubChem_Cell_line:CVCL_1110, SLKBase:3399, Wikidata:Q54808406 |
|
|
CVCL_1110 |
2026-08-15 04:19:56 |
39 |
Calu-1
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0608
|
Homo sapiens (Human)
|
Lung squamous cell carcinoma
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:833871 PMID:3518877 PMID:6582512 PMID:6935474 PMID:7017212 PMID:7459858 PMID:7736387 PMID:7972006 PMID:8385084 PMID:11583962 PMID:12068308 PMID:12794755 PMID:20164919 PMID:20215515 PMID:22460905 PMID:22961666 PMID:24002593 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26361996 PMID:26589293 PMID:28196595 PMID:29681454 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Male |
CaLu-1, CALU-1, Calu.1, CALU 1, Calu 1, CALU1, Calu1 |
|
|
BTO:BTO_0002940, CLO:CLO_0002191, EFO:EFO_0002151, CLDB:cl631, CLDB:cl632, CLDB:cl633, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-54, BioGRID_ORCS_Cell_line:233, BioSample:SAMN03471732, BioSample:SAMN10988371, cancercelllines:CVCL_0608, CancerTools:161905, CCRID:3101HUMTCHu192, Cell_Model_Passport:SIDM01545, ChEMBL-Cells:CHEMBL3308031, ChEMBL-Targets:CHEMBL613505, CLS:300141, Cosmic:724858, Cosmic:755615, Cosmic:929968, Cosmic:933574, Cosmic:934465, Cosmic:934541, Cosmic:1089224, Cosmic:1146872, Cosmic:1188586, Cosmic:1434968, Cosmic:2060525, Cosmic:2125218, Cosmic:2645023, Cosmic:2646653, Cosmic:2668264, Cosmic:2772160, DepMap:ACH-000511, ECACC:93120818, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724858, GEO:GSM108801, GEO:GSM108802, GEO:GSM206451, GEO:GSM253387, GEO:GSM274735, GEO:GSM274736, GEO:GSM434324, GEO:GSM784250, GEO:GSM794261, GEO:GSM817063, GEO:GSM843486, GEO:GSM886914, GEO:GSM887980, GEO:GSM1374430, GEO:GSM1374431, GEO:GSM1374432, IARC_TP53:8200, IARC_TP53:21263, ICLC:HTL95002, IGRhCellID:Calu1, IZSLER:BS TCL 76, LiGeA:CCLE_612, LINCS_HMS:50009, LINCS_LDP:LCL-1580, PharmacoDB:Calu1_178_2019, PRIDE:PXD002556, Progenetix:CVCL_0608, PubChem_Cell_line:CVCL_0608, Wikidata:Q54808423 |
|
|
CVCL_0608 |
2026-08-15 04:19:59 |
212 |
CAL-85-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1114
|
Homo sapiens (Human)
|
Breast carcinoma
|
Population: Asian., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7531416 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347
|
Cancer cell line
|
Female |
Cal-85-1, CAL 85-1, CAL85-1, CAL851, Centre Antoine Lacassagne-85-1 |
|
|
CLO:CLO_0002190, EFO:EFO_0005359, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473094, BioSample:SAMN10988345, cancercelllines:CVCL_1114, Cell_Model_Passport:SIDM00928, ChEMBL-Cells:CHEMBL3308700, ChEMBL-Targets:CHEMBL1075415, Cosmic:910852, Cosmic:2164987, Cosmic-CLP:910852, DepMap:ACH-000857, DSMZ:ACC-440, DSMZCellDive:ACC-440, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910852, GEO:GSM274639, GEO:GSM344363, GEO:GSM344413, GEO:GSM827163, GEO:GSM843484, GEO:GSM843485, GEO:GSM847247, GEO:GSM847457, GEO:GSM886913, GEO:GSM887979, GEO:GSM1172947, GEO:GSM1669657, IARC_TP53:21215, LiGeA:CCLE_496, LINCS_HMS:51112, LINCS_LDP:LCL-1465, Lonza:1212, PharmacoDB:CAL851_177_2019, Progenetix:CVCL_1114, PubChem_Cell_line:CVCL_1114, Wikidata:Q54808414 |
|
|
CVCL_1114 |
2026-08-15 04:19:56 |
8 |
CAL-51
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1110
|
|
|
Derived from metastatic site: Pleural effusion., Misspelling: Ca151; In Cosmic 1057761., Omics: Transcriptome analysis., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep RNAseq analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Omics: Array-based CGH., Microsatellite instability: Instable (MSI-low) (PubMed=12661003; PubMed=15677628; PubMed=31068700; Sanger)., Doubling time: 24 hours (PubMed=25984343); ~30 hours (PubMed=34339474); ~50-60 hours (DSMZ)., Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474)., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: GrayJW breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:2390488 PMID:10969801 PMID:11044355 PMID:12661003 PMID:12800145 PMID:15677628 PMID:19582160 PMID:20164919 PMID:20215515 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23122841 PMID:24176112 PMID:25485619 PMID:25984343 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:34339474 PMID:35839778
|
Cancer cell line
|
Female |
CAL 51, CAL51, Cal51, Centre Antoine Lacassagne-51 |
|
|
BTO:BTO:0000945, CLO:CLO_0002185, EFO:EFO_0005358, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473159, BioSample:SAMN10988576, Cell_Model_Passport:SIDM00933, ChEMBL-Cells:CHEMBL3308717, ChEMBL-Targets:CHEMBL1075411, Cosmic:687467, Cosmic:910927, Cosmic:1057761, Cosmic:2164986, Cosmic-CLP:910927, DepMap:ACH-000856, DSMZ:ACC-302, DSMZCellDive:ACC-302, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910927, GEO:GSM115099, GEO:GSM217567, GEO:GSM274645, GEO:GSM274646, GEO:GSM344362, GEO:GSM344412, GEO:GSM350521, GEO:GSM459702, GEO:GSM783973, GEO:GSM827162, GEO:GSM847246, GEO:GSM847456, GEO:GSM886909, GEO:GSM887975, GEO:GSM1172946, GEO:GSM1374429, GEO:GSM1664565, GEO:GSM1669652, IARC_TP53:21211, IGRhCellID:CAL51, LiGeA:CCLE_143, LINCS_HMS:50008, LINCS_LDP:LCL-1472, Lonza:1002, PharmacoDB:CAL51_172_2019, PRIDE:PXD000953, PRIDE:PXD030304, Progenetix:CVCL_1110, PubChem_Cell_line:CVCL_1110, SLKBase:3399, Wikidata:Q54808406 |
|
|
CVCL_1110 |
2026-08-15 04:19:59 |
39 |
CAL-78
Resource Report
Resource Website
|
RRID:CVCL_1809
|
Homo sapiens (Human)
|
Dedifferentiated chondrosarcoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:21590123 PMID:22460905 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
CAL 78, CAL78, Centre Antoine Lacassagne-78 |
|
|
CLO:CLO_0002189, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:586, BioSample:SAMN03473549, BioSample:SAMN10988508, cancercelllines:CVCL_1809, Cell_Model_Passport:SIDM00929, Cosmic:1995359, Cosmic-CLP:1290765, DepMap:ACH-000516, DSMZ:ACC-449, DSMZCellDive:ACC-449, EGA:EGAS00001000978, GDSC:1290765, GEO:GSM886912, GEO:GSM887978, GEO:GSM1669656, IARC_TP53:28271, LiGeA:CCLE_364, LINCS_LDP:LCL-1457, PharmacoDB:CAL78_176_2019, PRIDE:PXD030304, Progenetix:CVCL_1809, Wikidata:Q54808413 |
|
|
CVCL_1809 |
2026-08-15 04:19:56 |
0 |
BT-483
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2319
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:212572 PMID:10969801 PMID:16397213 PMID:16541312 PMID:17157791 PMID:18516279 PMID:19582160 PMID:19593635 PMID:20070913 PMID:20215515 PMID:22460905 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24162158 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:28889351 PMID:30894373 PMID:31068700 PMID:31395879 PMID:35839778
|
Cancer cell line
|
Female |
BT483 |
|
|
BTO:BTO_0003470, CLO:CLO_0002043, EFO:EFO_0001095, AddexBio:C0006013/4903, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-121, BioSample:SAMN03471598, BioSample:SAMN10988523, cancercelllines:CVCL_2319, Cell_Model_Passport:SIDM00892, ChEMBL-Cells:CHEMBL4295434, ChEMBL-Targets:CHEMBL4296404, Cosmic:687465, Cosmic:809238, Cosmic:871139, Cosmic:877445, Cosmic:894085, Cosmic:897415, Cosmic:904352, Cosmic:934521, Cosmic:949187, Cosmic:1018466, Cosmic:1044221, Cosmic:1046935, Cosmic:1047698, Cosmic:1136343, Cosmic:1152524, Cosmic:1287891, Cosmic:1289384, Cosmic:1603192, Cosmic:1995349, Cosmic:2165017, Cosmic:2750526, Cosmic-CLP:949093, DepMap:ACH-000818, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:949093, GEO:GSM344342, GEO:GSM344392, GEO:GSM350551, GEO:GSM421862, GEO:GSM783946, GEO:GSM827462, GEO:GSM886893, GEO:GSM887958, GEO:GSM1008892, GEO:GSM1053737, GEO:GSM1172854, GEO:GSM1172942, GEO:GSM1215263, GEO:GSM1238129, GEO:GSM1669631, IARC_TP53:18374, IARC_TP53:24359, LiGeA:CCLE_071, LINCS_HMS:50107, LINCS_LDP:LCL-1309, PharmacoDB:BT483_110_2019, PRIDE:PXD030304, Progenetix:CVCL_2319, PubChem_Cell_line:CVCL_2319, Wikidata:Q54798468 |
|
|
CVCL_2319 |
2026-08-15 04:19:10 |
9 |
BT-20
Resource Report
Resource Website
500+ mentions
Discontinued
|
RRID:CVCL_0178
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: EGFR genetic alteration cell panel (ATCC TCP-1027)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:833871 PMID:3518877 PMID:4831449 PMID:6220172 PMID:6582512 PMID:7017212 PMID:7459858 PMID:10969801 PMID:11414198 PMID:11789735 PMID:12661003 PMID:12800145 PMID:13611537 PMID:16397213 PMID:16541312 PMID:17157791 PMID:19582160 PMID:19593635 PMID:20164919 PMID:20215515 PMID:21778573 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28889351 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
BT 20, BT20 |
|
|
BTO:BTO_0001466, CLO:CLO_0002041, EFO:EFO_0001092, MCCL:MCC:0000069, CLDB:cl493, CLDB:cl494, CLDB:cl495, ABM:T8959, AddexBio:C0006014/4910, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ATCC:CRL-7912, ATCC:HTB-19, BioSample:SAMN03471671, BioSample:SAMN03472738, BioSample:SAMN10987894, cancercelllines:CVCL_0178, CCRID:1101HUM-PUMC000335, Cell_Model_Passport:SIDM00893, ChEMBL-Cells:CHEMBL3307766, ChEMBL-Targets:CHEMBL613870, CLS:300130, Cosmic:687463, Cosmic:871137, Cosmic:904350, Cosmic:906801, Cosmic:934519, Cosmic:979719, Cosmic:991332, Cosmic:997914, Cosmic:1010923, Cosmic:1017159, Cosmic:1018465, Cosmic:1046932, Cosmic:1047701, Cosmic:1136370, Cosmic:1287931, Cosmic:1289382, Cosmic:1434946, Cosmic:1524352, Cosmic:1603190, Cosmic:1609471, Cosmic:1995348, Cosmic:2009507, Cosmic:2036672, Cosmic:2301232, Cosmic:2301522, Cosmic:2307195, Cosmic:2318378, Cosmic:2361352, Cosmic-CLP:906801, DepMap:ACH-000536, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906801, GEO:GSM184390, GEO:GSM184391, GEO:GSM350505, GEO:GSM421860, GEO:GSM459725, GEO:GSM783945, GEO:GSM827574, GEO:GSM843445, GEO:GSM843446, GEO:GSM847197, GEO:GSM847452, GEO:GSM886891, GEO:GSM887956, GEO:GSM1053689, GEO:GSM1172940, GEO:GSM1238127, GEO:GSM1374406, GEO:GSM1374407, GEO:GSM1401673, GEO:GSM1669629, IARC_TP53:3, IBRC:C10149, IGRhCellID:BT20, KCLB:60061, LiGeA:CCLE_451, LINCS_HMS:50105, LINCS_LDP:LCL-1476, Lonza:114, NCBI_Iran:C434, PharmacoDB:BT20_108_2019, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0178, PubChem_Cell_line:CVCL_0178, SLKBase:3481, TOKU-E:693, Wikidata:Q52392673 |
|
|
CVCL_0178 |
2026-08-15 04:19:10 |
921 |
BT-549
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_1092
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Triple negative breast cancer (TNBC) cell line.
|
PMID:1961733 PMID:6500159 PMID:7902062 PMID:9331090 PMID:9561029 PMID:9671407 PMID:10700174 PMID:10862037 PMID:10969801 PMID:11343771 PMID:15153330 PMID:15677628 PMID:15748285 PMID:16397213 PMID:16541312 PMID:17088437 PMID:17157791 PMID:18277095 PMID:18516279 PMID:19372543 PMID:19582160 PMID:19593635 PMID:19727395 PMID:20164919 PMID:20215515 PMID:20679594 PMID:21552935 PMID:21778573 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22585861 PMID:22628656 PMID:23151021 PMID:23601657 PMID:23637631 PMID:23856246 PMID:23933261 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:25984343 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:28287265 PMID:28889351 PMID:30613774 PMID:30894373 PMID:31068700 PMID:31733513 PMID:31978347 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Female |
BT 549, BT.549, BT549 |
|
|
BTO:BTO_0002548, CLO:CLO_0002044, EFO:EFO_0001096, CLDB:cl7128, AddexBio:C0006017/4962, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-6647, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:HTB-122, BioGRID_ORCS_Cell_line:510, BioSample:SAMN03471380, BioSample:SAMN10988343, cancercelllines:CVCL_1092, CCRID:1101HUM-PUMC000336, CCRID:3101HUMTCHu93, Cell_Model_Passport:SIDM00122, ChEMBL-Cells:CHEMBL3308490, ChEMBL-Targets:CHEMBL614072, CLS:300132, Cosmic:687466, Cosmic:850826, Cosmic:871140, Cosmic:875881, Cosmic:877446, Cosmic:897414, Cosmic:904353, Cosmic:934522, Cosmic:949188, Cosmic:974237, Cosmic:1010925, Cosmic:1018476, Cosmic:1044204, Cosmic:1044234, Cosmic:1046924, Cosmic:1047700, Cosmic:1092593, Cosmic:1136371, Cosmic:1152525, Cosmic:1175830, Cosmic:1176638, Cosmic:1287920, Cosmic:1289385, Cosmic:1305386, Cosmic:1308998, Cosmic:1312372, Cosmic:1434948, Cosmic:1603193, Cosmic:1609466, Cosmic:1995350, Cosmic:1998435, Cosmic:2036671, Cosmic:2164983, Cosmic:2301524, Cosmic:2318374, Cosmic:2361359, Cosmic-CLP:905951, DepMap:ACH-000288, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905951, GEO:GSM2121, GEO:GSM50181, GEO:GSM50245, GEO:GSM217614, GEO:GSM274638, GEO:GSM274662, GEO:GSM320176, GEO:GSM344343, GEO:GSM344393, GEO:GSM350517, GEO:GSM378149, GEO:GSM421863, GEO:GSM750775, GEO:GSM783947, GEO:GSM799318, GEO:GSM799381, GEO:GSM827358, GEO:GSM839031, GEO:GSM843477, GEO:GSM843478, GEO:GSM843479, GEO:GSM843480, GEO:GSM846287, GEO:GSM847199, GEO:GSM847454, GEO:GSM886894, GEO:GSM887959, GEO:GSM1008893, GEO:GSM1053686, GEO:GSM1153387, GEO:GSM1172855, GEO:GSM1172943, GEO:GSM1181340, GEO:GSM1181341, GEO:GSM1214578, GEO:GSM1238130, GEO:GSM1374412, GEO:GSM1374413, GEO:GSM1401657, GEO:GSM1669632, GEO:GSM2124662, IARC_TP53:5, IARC_TP53:28243, IBRC:C10151, ICLC:HTL02006, KCB:KCB 2011118YJ, LiGeA:CCLE_360, LINCS_HMS:50108, LINCS_LDP:LCL-1310, Lonza:116, NCI-DTP:BT-549, PharmacoDB:BT549_111_2019, PRIDE:PXD003539, PRIDE:PXD005292, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_1092, PubChem_Cell_line:CVCL_1092, SKY/M-FISH/CGH:1458, SLKBase:3393, TOKU-E:696, Wikidata:Q54798471 |
|
|
CVCL_1092 |
2026-08-15 04:19:10 |
2466 |
BT-474
Resource Report
Resource Website
1000+ mentions
Discontinued
|
RRID:CVCL_0179
|
Homo sapiens (Human)
|
Invasive breast carcinoma of no special type
|
Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870)., Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: EGFR genetic alteration cell panel (ATCC TCP-1027)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
|
PMID:94035 PMID:212572 PMID:1961733 PMID:6582512 PMID:7842014 PMID:9671407 PMID:10862037 PMID:10969801 PMID:11343771 PMID:11687795 PMID:12353263 PMID:12800145 PMID:16142302 PMID:16195238 PMID:16397213 PMID:16417655 PMID:16541312 PMID:17157791 PMID:17334996 PMID:18386134 PMID:18516279 PMID:19582160 PMID:19593635 PMID:19671800 PMID:19727395 PMID:20070913 PMID:20164919 PMID:20215515 PMID:21247443 PMID:22460905 PMID:22585861 PMID:23151021 PMID:23601657 PMID:23671654 PMID:24094812 PMID:24162158 PMID:24176112 PMID:24389870 PMID:24456987 PMID:25485619 PMID:25877200 PMID:25892236 PMID:25960936 PMID:25984343 PMID:26218769 PMID:26589293 PMID:26865974 PMID:27362937 PMID:27378269 PMID:27397505 PMID:28196595 PMID:28287265 PMID:28889351 PMID:30894373 PMID:31068700 PMID:32942617 PMID:35839778
|
Cancer cell line
|
Female |
Bt-474, BT474 |
|
|
BTO:BTO_0001932, CLO:CLO_0002042, EFO:EFO_0001093, MCCL:MCC:0000070, CLDB:cl497, CLDB:cl498, CLDB:cl4997, AddexBio:C0006012/4902, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:CRL-7913, ATCC:HTB-20, BCRC:60359, BCRJ:0353, BioSample:SAMN01821539, BioSample:SAMN01821618, BioSample:SAMN03473029, BioSample:SAMN10988308, BioSamples:SAMEA3516847, BioSamples:SAMEA3516848, BioSamples:SAMEA3516849, cancercelllines:CVCL_0179, CCRID:1101HUM-PUMC000129, CCRID:1102HUM-NIFDC00023, CCRID:3101HUMTCHu143, CCRID:4201HUM-CCTCC00636, Cell_Model_Passport:SIDM00963, ChEMBL-Cells:CHEMBL3307636, ChEMBL-Targets:CHEMBL614529, CLS:300131, Cosmic:687464, Cosmic:871138, Cosmic:904351, Cosmic:923058, Cosmic:934520, Cosmic:946359, Cosmic:970088, Cosmic:979721, Cosmic:1000122, Cosmic:1017168, Cosmic:1018460, Cosmic:1046934, Cosmic:1047699, Cosmic:1071903, Cosmic:1129654, Cosmic:1136353, Cosmic:1176605, Cosmic:1287890, Cosmic:1289383, Cosmic:1308996, Cosmic:1434947, Cosmic:1523771, Cosmic:1603191, Cosmic:1609475, Cosmic:1945863, Cosmic:2165003, Cosmic:2301523, Cosmic:2318376, Cosmic:2361356, Cosmic-CLP:946359, DepMap:ACH-000927, DSMZ:ACC-64, DSMZCellDive:ACC-64, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:946359, GEO:GSM1716, GEO:GSM1725, GEO:GSM69198, GEO:GSM73557, GEO:GSM73702, GEO:GSM115110, GEO:GSM147888, GEO:GSM147957, GEO:GSM149981, GEO:GSM149989, GEO:GSM149997, GEO:GSM155210, GEO:GSM184392, GEO:GSM184393, GEO:GSM213707, GEO:GSM213717, GEO:GSM213718, GEO:GSM213719, GEO:GSM213737, GEO:GSM213740, GEO:GSM213743, GEO:GSM213745, GEO:GSM217615, GEO:GSM274657, GEO:GSM276780, GEO:GSM320173, GEO:GSM344341, GEO:GSM344391, GEO:GSM350504, GEO:GSM388211, GEO:GSM421861, GEO:GSM533397, GEO:GSM533412, GEO:GSM590105, GEO:GSM679677, GEO:GSM679678, GEO:GSM679679, GEO:GSM679680, GEO:GSM679681, GEO:GSM679682, GEO:GSM679683, GEO:GSM679684, GEO:GSM679685, GEO:GSM679686, GEO:GSM679687, GEO:GSM679688, GEO:GSM679689, GEO:GSM679690, GEO:GSM679691, GEO:GSM783958, GEO:GSM799168, GEO:GSM799169, GEO:GSM799170, GEO:GSM799171, GEO:GSM799172, GEO:GSM799173, GEO:GSM843476, GEO:GSM847198, GEO:GSM847453, GEO:GSM886892, GEO:GSM887957, GEO:GSM903063, GEO:GSM903064, GEO:GSM903065, GEO:GSM903066, GEO:GSM903067, GEO:GSM903068, GEO:GSM903069, GEO:GSM967821, GEO:GSM1008891, GEO:GSM1053692, GEO:GSM1172853, GEO:GSM1172941, GEO:GSM1214587, GEO:GSM1238128, GEO:GSM1264068, GEO:GSM1264073, GEO:GSM1264110, GEO:GSM1264115, GEO:GSM1374408, GEO:GSM1374409, GEO:GSM1374410, GEO:GSM1401649, GEO:GSM1669630, GEO:GSM2176271, GEO:GSM2176272, Hysigen:TCH-C139, IARC_TP53:4, IBRC:C10140, ICLC:HTL00008, IGRhCellID:BT474, KCB:KCB 2011115YJ, KCLB:60062, LiGeA:CCLE_516, LINCS_HMS:50106, LINCS_LDP:LCL-1308, NCBI_Iran:C435, PharmacoDB:BT474_109_2019, PRIDE:PXD002281, PRIDE:PXD002635, PRIDE:PXD004357, PRIDE:PXD005390, PRIDE:PXD008222, PRIDE:PXD030304, Progenetix:CVCL_0179, PubChem_Cell_line:CVCL_0179, TOKU-E:694, Wikidata:Q54798460 |
|
|
CVCL_0179 |
2026-08-15 04:19:10 |
2878 |
BxPC-3
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0186
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Caution: Additional TP53 mutation in c.793C>T indicated incorrectly in PubMed=1630814., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1630814 PMID:1764370 PMID:3754176 PMID:7961102 PMID:8026879 PMID:8194712 PMID:8286197 PMID:8426738 PMID:9788440 PMID:10027410 PMID:10408907 PMID:11115575 PMID:11169959 PMID:12692724 PMID:15126341 PMID:15367885 PMID:15688027 PMID:16912165 PMID:18298655 PMID:18380791 PMID:20037478 PMID:20164919 PMID:20418756 PMID:21607521 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26589293 PMID:27073551 PMID:27229158 PMID:27259358 PMID:27397505 PMID:27910856 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:32782605 PMID:35839778
|
Cancer cell line
|
Female |
BxPc-3, BXPC-3, Bx-PC3, BXPC3, BxPC3, BxPc3, Biopsy xenograft of Pancreatic Carcinoma line-3 |
|
|
BTO:BTO_0001861, CLO:CLO_0002065, EFO:EFO_0002709, MCCL:MCC:0000077, CLDB:cl516, CLDB:cl517, CLDB:cl518, AddexBio:C0018003/27, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1687, BCRC:60283, BCRJ:0056, BioGRID_ORCS_Cell_line:162, BioSample:SAMN03470942, BioSample:SAMN10987955, cancercelllines:CVCL_0186, CCRID:1101HUM-PUMC000274, CCRID:3101HUMTCHu012, Cell_Model_Passport:SIDM00132, CGH-DB:161-1, CGH-DB:9272-4, ChEMBL-Cells:CHEMBL3307637, ChEMBL-Targets:CHEMBL614530, CLS:305031, Cosmic:707248, Cosmic:730531, Cosmic:736269, Cosmic:755301, Cosmic:808164, Cosmic:872995, Cosmic:906693, Cosmic:913310, Cosmic:918055, Cosmic:922251, Cosmic:923165, Cosmic:932515, Cosmic:933516, Cosmic:947403, Cosmic:948372, Cosmic:949321, Cosmic:968108, Cosmic:1006369, Cosmic:1198209, Cosmic:1299295, Cosmic:1366281, Cosmic:1477430, Cosmic:1518232, Cosmic:1534316, Cosmic:1571773, Cosmic:1644317, Cosmic:1768263, Cosmic:1945873, Cosmic:2434095, Cosmic:2820476, Cosmic-CLP:906693, DepMap:ACH-000535, DSMZ:ACC-760, DSMZCellDive:ACC-760, ECACC:93120816, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906693, GEO:GSM206447, GEO:GSM621894, GEO:GSM784699, GEO:GSM886896, GEO:GSM887961, GEO:GSM1024397, GEO:GSM1374415, GEO:GSM1374416, GEO:GSM1374417, GEO:GSM1588608, GEO:GSM1588620, GEO:GSM1669634, GEO:GSM1906991, GEO:GSM1906992, GEO:GSM1906993, IARC_TP53:312, ICLC:HTL96011, IZSLER:BS TCL 4, KCB:KCB 200428YJ, LiGeA:CCLE_491, LINCS_LDP:LCL-1731, Lonza:1013, PharmacoDB:BxPC3_149_2019, PRIDE:PXD003198, PRIDE:PXD030304, PRIDE:PXD032263, Progenetix:CVCL_0186, PubChem_Cell_line:CVCL_0186, SKY/M-FISH/CGH:1995, TOKU-E:707, Ubigene:YC-C015, Wikidata:Q54798758 |
|
|
CVCL_0186 |
2026-08-15 04:19:18 |
1338 |
CFPAC-1
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1119
|
Homo sapiens (Human)
|
Cystic fibrosis
|
Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1692630 PMID:10027410 PMID:10408907 PMID:11169959 PMID:11787853 PMID:12800145 PMID:14695172 PMID:15126341 PMID:15367885 PMID:15463957 PMID:15688027 PMID:16912165 PMID:18380791 PMID:19077451 PMID:20164919 PMID:20418756 PMID:22460905 PMID:22585861 PMID:25167228 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26589293 PMID:27259358 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
CFPac-1, CF PAC-1, CF-PAC1, CF-Pac1, CF Pac1, CFPAC1, CFPac1, CFPAC |
|
|
BTO:BTO_0004738, CLO:CLO_0002395, EFO:EFO_0006551, CLDB:cl705, CLDB:cl7121, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1918, BioGRID_ORCS_Cell_line:439, BioSample:SAMN03471976, BioSample:SAMN10987887, cancercelllines:CVCL_1119, CCRID:1101HUM-PUMC000245, CCRID:3101HUMTCHu112, CCRID:4201HUM-CCTCC00249, CCTCC:GDC0249, Cell_Model_Passport:SIDM00130, CGH-DB:164-1, CGH-DB:9273-4, ChEMBL-Cells:CHEMBL3308032, ChEMBL-Targets:CHEMBL613506, CLS:305066, Cosmic:710854, Cosmic:868245, Cosmic:872998, Cosmic:906821, Cosmic:913305, Cosmic:922259, Cosmic:923168, Cosmic:932518, Cosmic:948375, Cosmic:948741, Cosmic:949322, Cosmic:1006363, Cosmic:1122343, Cosmic:1198207, Cosmic:1299298, Cosmic:1358477, Cosmic:1518233, Cosmic:1571776, Cosmic:2434110, Cosmic-CLP:906821, DepMap:ACH-000138, ECACC:91112501, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906821, GEO:GSM206454, GEO:GSM244428, GEO:GSM621903, GEO:GSM784694, GEO:GSM886925, GEO:GSM887991, GEO:GSM1024400, GEO:GSM1374446, GEO:GSM1374447, GEO:GSM1374448, GEO:GSM1669672, IARC_TP53:2839, ICLC:HTL01019, IZSLER:BS TCL 166, KCB:KCB 200730YJ, LiGeA:CCLE_601, LINCS_LDP:LCL-1748, PharmacoDB:CFPAC1_193_2019, PRIDE:PXD003198, PRIDE:PXD030304, PRIDE:PXD032263, Progenetix:CVCL_1119, PubChem_Cell_line:CVCL_1119, SKY/M-FISH/CGH:1998, Wikidata:Q28199352 |
|
|
CVCL_1119 |
2026-08-15 04:20:19 |
386 |
GOS-3
Resource Report
Resource Website
1+ mentions
Contaminated
|
DSMZ Cat# ACC-408, RRID:CVCL_2050
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a U-343MGa derivative (PubMed=22570425). Originally thought to originate from the brain of a 55 year old patient with a mixed astro-oligodendroglioma (grade II/III)..
|
PMID:9760066 PMID:22460905 PMID:22570425 PMID:25877200 PMID:26589293 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
GOS 3, GOS3 |
DSMZ |
ACC-408 |
CLO:CLO_0003550, ArrayExpress:E-MTAB-2770, BioSample:SAMN03151979, BioSample:SAMN03470943, BioSample:SAMN10987798, cancercelllines:CVCL_2050, CCRID:1101HUM-PUMC000467, Cell_Model_Passport:SIDM01635, DepMap:ACH-000027, DSMZ:ACC-408, DSMZCellDive:ACC-408, GEO:GSM887026, GEO:GSM888096, IARC_TP53:21347, LiGeA:CCLE_213, LINCS_LDP:LCL-1406, PharmacoDB:GOS3_408_2019, Progenetix:CVCL_2050, Wikidata:Q54871613 |
cvcl_4773 |
|
CVCL_2050 |
2026-08-15 04:34:59 |
3 |
GP2d
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2450
|
Homo sapiens (Human)
|
Colon adenocarcinoma
|
Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:7601566 PMID:10051639 PMID:10737795 PMID:11226274 PMID:16418264 PMID:18258742 PMID:20164919 PMID:20606684 PMID:22460905 PMID:23272949 PMID:24755471 PMID:25485619 PMID:25877200 PMID:25926053 PMID:25984343 PMID:26589293 PMID:29101300 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Female |
Gp2d, Gp2D, GP2D |
|
|
CLO:CLO_0003554, CLO:CLO_0009961, EFO:EFO_0006575, CLDB:cl1511, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, BioSample:SAMN03472980, BioSample:SAMN10988004, cancercelllines:CVCL_2450, Cell_Model_Passport:SIDM00536, ColonAtlas:GP2d, Cosmic:907292, Cosmic:948863, Cosmic:995380, Cosmic:1223138, Cosmic:1609504, Cosmic:2301973, DepMap:ACH-000982, ECACC:95090714, EGA:EGAS00001000610, EGA:EGAS00001002554, GEO:GSM887027, GEO:GSM888097, GEO:GSM1346870, GEO:GSM1374483, GEO:GSM1448105, IARC_TP53:21352, LiGeA:CCLE_010, LINCS_LDP:LCL-1188, PharmacoDB:Gp2D_410_2019, PRIDE:PXD005354, PRIDE:PXD005355, Progenetix:CVCL_2450, Wikidata:Q54871632 |
|
|
CVCL_2450 |
2026-08-15 04:35:01 |
7 |